{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:41:27Z","timestamp":1760910087996,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RR025761","TR000006"],"award-info":[{"award-number":["RR025761","TR000006"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006975","name":"Indiana Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.cyto.2021.155634","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T01:48:12Z","timestamp":1625276892000},"page":"155634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinical applications of thrombopoietin silencing: A possible therapeutic role in COVID-19?"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2405-5818","authenticated-orcid":false,"given":"Vincent J.","family":"Alentado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison R.","family":"Moliterno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward F.","family":"Srour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7293-0088","authenticated-orcid":false,"given":"Melissa A.","family":"Kacena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cyto.2021.155634_b0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/bjh.12772","article-title":"Thrombopoietin from beginning to end","volume":"165","author":"Hitchcock","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"6481","key":"10.1016\/j.cyto.2021.155634_b0010","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/369568a0","article-title":"Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin","volume":"369","author":"Kaushansky","year":"1994","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cyto.2021.155634_b0015","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1182\/blood.V87.11.4544.bloodjournal87114544","article-title":"Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice","volume":"87","author":"Ku","year":"1996","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cyto.2021.155634_b0020","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1073\/pnas.96.6.3132","article-title":"Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia","volume":"96","author":"Ihara","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"10","key":"10.1016\/j.cyto.2021.155634_b0025","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1074\/jbc.270.10.4979","article-title":"The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl","volume":"270","author":"Drachman","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.cyto.2021.155634_b0030","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s12015-020-09974-9","article-title":"Aging-related reduced expression of CXCR4 on bone marrow mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell defects","volume":"16","author":"Singh","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"issue":"7","key":"10.1016\/j.cyto.2021.155634_b0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/jir.2005.25.407","article-title":"Thrombopoietin production in wild-type and interleukin-6 knockout mice with acute inflammation","volume":"25","author":"Burmester","year":"2005","journal-title":"J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res."},{"issue":"9","key":"10.1016\/j.cyto.2021.155634_b0040","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"Kumari","year":"2016","journal-title":"Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med."},{"issue":"2","key":"10.1016\/j.cyto.2021.155634_b0045","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2141.1991.tb04534.x","article-title":"Elevated serum interleukin-6 levels in patients with reactive thrombocytosis","volume":"79","author":"Hollen","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cyto.2021.155634_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","volume":"111","author":"Liu","year":"2020","journal-title":"J. Autoimmun."},{"issue":"9","key":"10.1016\/j.cyto.2021.155634_b0055","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2018-11-882993","article-title":"Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms","volume":"133","author":"Jackson","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2021.155634_b0060","doi-asserted-by":"crossref","unstructured":"W.B. Mitchell, Thromboinflammation in COVID-19 acute lung injury, Paediatr Respir Rev. Published online June 11, 2020. doi:10.1016\/j.prrv.2020.06.004.","DOI":"10.1016\/j.prrv.2020.06.004"},{"issue":"8","key":"10.1016\/j.cyto.2021.155634_b0065","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41587-020-0634-9","article-title":"Focus shifts to antibody cocktails for COVID-19 cytokine storm","volume":"38","author":"Harrison","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cyto.2021.155634_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100434","article-title":"Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series","volume":"24","author":"Rapkiewicz","year":"2020","journal-title":"EClinicalMedicine."},{"issue":"9","key":"10.1016\/j.cyto.2021.155634_b0075","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1182\/blood.2020008043","article-title":"Clinical insights into the origins of thrombosis in myeloproliferative neoplasms","volume":"137","author":"Moliterno","year":"2021","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cyto.2021.155634_b0080","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood-2016-10-696005","article-title":"Myeloproliferative neoplasm stem cells","volume":"129","author":"Mead","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cyto.2021.155634_b0085","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/17474086.2019.1617129","article-title":"The role of the thrombopoietin receptor MPL in myeloproliferative neoplasms: recent findings and potential therapeutic applications","volume":"12","author":"Vainchenker","year":"2019","journal-title":"Expert Rev Hematol."},{"key":"10.1016\/j.cyto.2021.155634_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.641613","article-title":"The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN","volume":"11","author":"Spivak","year":"2021","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.cyto.2021.155634_b0095","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1080\/10428194.2017.1312371","article-title":"Essential thrombocythemia: a review of the clinical features, diagnostic challenges, and treatment modalities in the era of molecular discovery","volume":"58","author":"Chuzi","year":"2017","journal-title":"Leuk. Lymphoma"},{"issue":"11","key":"10.1016\/j.cyto.2021.155634_b0100","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1182\/blood.V90.11.4369","article-title":"High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice","volume":"90","author":"Villeval","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cyto.2021.155634_b0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jamaoncol.2015.89","article-title":"Myeloproliferative Neoplasms: A Contemporary Review","volume":"1","author":"Tefferi","year":"2015","journal-title":"JAMA Oncol."},{"issue":"9","key":"10.1016\/j.cyto.2021.155634_b0110","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1182\/blood.V98.9.2720","article-title":"Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis","volume":"98","author":"Kaser","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cyto.2021.155634_b0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.cyto.2021.155634_b0120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0145-2126(99)00201-5","article-title":"Analysis of thrombopoietin receptor (c-mpl) mRNA expression in de novo acute myeloid leukemia","volume":"24","author":"Schr\u00f6der","year":"2000","journal-title":"Leuk. Res."},{"issue":"20","key":"10.1016\/j.cyto.2021.155634_b0125","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/bloodadvances.2019000250","article-title":"Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice","volume":"3","author":"Shirai","year":"2019","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.cyto.2021.155634_b0130","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1073\/pnas.94.2.663","article-title":"Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets","volume":"94","author":"M\u00f6hle","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"5","key":"10.1016\/j.cyto.2021.155634_b0135","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.molmed.2004.03.007","article-title":"Recent advances in understanding serotonin regulation of cardiovascular function","volume":"10","author":"C\u00f4t\u00e9","year":"2004","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.cyto.2021.155634_b0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01787021","article-title":"The role of calcium channels and serotonin (5-HT2) receptors for tumour cell lodgement in the liver","volume":"7","author":"Skolnik","year":"1989","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"10.1016\/j.cyto.2021.155634_b0145","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood-2004-02-0434","article-title":"Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis","volume":"104","author":"Camerer","year":"2004","journal-title":"Blood"},{"issue":"37","key":"10.1016\/j.cyto.2021.155634_b0150","doi-asserted-by":"crossref","first-page":"37ra45","DOI":"10.1126\/scitranslmed.3000697","article-title":"Safety and antithrombotic efficacy of moderate platelet count reduction by thrombopoietin inhibition in primates","volume":"2","author":"Tucker","year":"2010","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.cyto.2021.155634_b0155","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/art.1780310614","article-title":"Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides","volume":"31","author":"Houssiau","year":"1988","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.cyto.2021.155634_b0160","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.bor.0000231910.42666.31","article-title":"The role of megakaryocytes in skeletal homeostasis and rheumatoid arthritis","volume":"18","author":"Kacena","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"issue":"9","key":"10.1016\/j.cyto.2021.155634_b0165","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nrrheum.2012.118","article-title":"Platelets: active players in the pathogenesis of arthritis and SLE","volume":"8","author":"Boilard","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9","key":"10.1016\/j.cyto.2021.155634_b0170","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1182\/blood.V90.9.3423","article-title":"Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin","volume":"90","author":"Bunting","year":"1997","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cyto.2021.155634_b0175","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/jth.14808","article-title":"Antisense oligonucleotide targeting of thrombopoietin represents a novel platelet depletion method to assess the immunomodulatory role of platelets","volume":"18","author":"Barrett","year":"2020","journal-title":"J Thromb Haemost JTH."},{"key":"10.1016\/j.cyto.2021.155634_b0180","doi-asserted-by":"crossref","unstructured":"D. Desai, A. Borodovsky, W.P. Davis, et al. Development of liver-specific thrombopoietin targeted sirnas: impact on platelet count, megakaryocyte mass, and hematopoietic progenitors in normal and MPN murine models. Blood 132(Supplement 1) (2018) 4329\u20134329. doi: 10.1182\/blood-2018-99-117142.","DOI":"10.1182\/blood-2018-99-117142"},{"key":"10.1016\/j.cyto.2021.155634_b0185","unstructured":"COVID-19 Dashboard at Johns Hopkins University. Accessed September 21, 2020. https:\/\/coronavirus.jhu.edu\/map.html."},{"issue":"7","key":"10.1016\/j.cyto.2021.155634_b0190","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41375-020-0891-0","article-title":"The Janus kinase 1\/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation","volume":"34","author":"La Ros\u00e9e","year":"2020","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.cyto.2021.155634_b0195","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1055\/s-0040-1714274","article-title":"Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis","volume":"46","author":"Thachil","year":"2020","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.cyto.2021.155634_b0200","doi-asserted-by":"crossref","unstructured":"D.W. Nauen, J.E. Hooper, C.M. Stewart, I.H. Solomon, Assessing brain capillaries in coronavirus disease 2019, JAMA Neurol. Published online February 12, 2021. doi: 10.1001\/jamaneurol.2021.0225.","DOI":"10.1001\/jamaneurol.2021.0225"},{"key":"10.1016\/j.cyto.2021.155634_b0205","doi-asserted-by":"crossref","unstructured":"P. Mehta, C. Ciurtin, M. Scully, M. Levi, R.C. Chambers, JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk, Eur. Respir. J. Published online July 6, 2020. doi:10.1183\/13993003.01919-2020.","DOI":"10.1183\/13993003.01919-2020"},{"issue":"7648","key":"10.1016\/j.cyto.2021.155634_b0210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature21706","article-title":"The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors","volume":"544","author":"Lefran\u00e7ais","year":"2017","journal-title":"Nature"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621002209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621002209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:02:13Z","timestamp":1760907733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621002209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":42,"alternative-id":["S1043466621002209"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155634","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical applications of thrombopoietin silencing: A possible therapeutic role in COVID-19?","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155634","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155634"}}